Brian M. Culley - 12 Mar 2026 Form 4 Insider Report for Lineage Cell Therapeutics, Inc. (LCTX)

Role: President and CEO, Director
Signature: /s/ Brian M. Culley
Issuer symbol: LCTX
Transactions as of: 12 Mar 2026
Net transactions value: +$24,375
Form type: 4
Filing time: 12 Mar 2026, 16:05:10 UTC
Previous filing: 06 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Culley Brian M	President and CEO, Director	C/O LINEAGE CELL THERAPEUTICS, 2173 SALK AVENUE, SUITE 200, CARLSBAD	/s/ Brian M. Culley	12 Mar 2026	0001310683

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LCTX	Common Shares	Purchase	$24,375	+15,000	+6.2%	$1.62	255,516	12 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.61 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.61 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.